Eon Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.70 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.30 M
as on 16-11-2024
- Revenue 77.58%
(FY 2023)
- Profit 85.89%
(FY 2023)
- Ebitda 69.34%
(FY 2023)
- Net Worth 78.86%
(FY 2023)
- Total Assets 34.87%
(FY 2023)
About Eon Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.40 Cr. The company has closed loans amounting to ₹5.30 M, as per Ministry of Corporate Affairs (MCA) records.
Naynaben Savaliya, Donasiya Bachubhai, Nirav Khunt, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GJ2007PTC050742
- Company No.
050742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Eon Meditech Private Limited offer?
Eon Meditech Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, ENT Surgical Equipment & Supplies, ENT Instrument, Scalpels, Needles & Scissors, Hemostatic Forcep, Orthopedic Equipment & Supplies, Orthopedic Trauma Implants, Orthopedic Implants, Stainless Steel Cannula.
Who are the key members and board of directors at Eon Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naynaben Savaliya  | Director | 26-Mar-2012 | Current |
| Donasiya Bachubhai | Director | 07-Jun-2019 | Current |
| Nirav Khunt | Director | 07-Jun-2019 | Current |
| Sandip Savaliya | Director | 04-May-2007 | Current |
Financial Performance of Eon Meditech.
Eon Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 77.58% increase. The company also saw a substantial improvement in profitability, with a 85.89% increase in profit. The company's net worth Soared by an impressive increase of 78.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eon Meditech?
In 2023, Eon Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 25 Jun 2021 | ₹1.85 Cr | Open |
Sidbi Creation Date: 29 Jul 2020 | ₹5.00 M | Open |
Others Creation Date: 09 Oct 2018 | ₹0.50 M | Open |
How Many Employees Work at Eon Meditech?
Eon Meditech has a workforce of 147 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eon Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eon Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
